01-10-2006 | Commentary
Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al
Published in: Arthritis Research & Therapy | Issue 5/2006
Login to get access